我要投票 SHINVA新华在医疗器械行业中的票数:370
· 外 推 电 报 ·
2025-06-20 12:15:42 星期五

【SHINVA新华是哪个国家的品牌?】

SHINVA新华是什么牌子?「SHINVA新华」是 山东新华医疗器械股份有限公司 旗下著名品牌。该品牌发源于山东,由创始人许尚峰在1993期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力SHINVA新华品牌出海!将品牌入驻外推网,定制SHINVA新华品牌推广信息,可以显著提高SHINVA新华产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

2002年9月,山东新华医疗器械股份有限公司在上海证券交易所上市,现为中国医疗器械行业协会会长单位。

山东新华医疗器械股份有限公司始终坚持拼搏诚信的齐鲁文化、以用户为中心的现代企业文化为企业核心价值观,用目标鼓舞士气,用发展凝聚人心,用创新提升素质,用文化打造实力,坚定不移地走健康产业之路,坚定不移地走技术创新之路,坚定不移地走资本运作之路,拥有医疗器械及装备、制药装备、医疗服务三大业务板块。

在医疗器械板块,已形成九大配置精良、技术完备的先进产品线,涵盖感染控制、放疗及影像、手术器械及骨科、手术室工程及设备、口腔设备及耗材、体外诊断试剂及仪器、生物材料及耗材、透析设备及耗材、医用环保及其他领域。

制药装备板块,由生物制药、特种输液、中药制剂、固体制剂四大工程技术中心组成,下设八个产品技术分厂和五个控股公司,集制药装备研发、制造及销售为一体。在常规制药装备生产之外,提供着“制药工艺、制药装备、制药工程”三位一体的优质服务;同时,为化学药、生物药、植物药工厂的建设提供整包服务,为客户解决一切后顾之忧。

在医疗服务领域,新华医疗持续提升着品牌竞争力和美誉度。凭借专业的投资、建设、运营及采购和服务平台,打造具有先进医疗理念、前沿科研水平、品牌经营连锁、资源有机融合的现代化医院集团。与此同时,新华医疗也在积极拓展着肾脏健康服务,利用公司专业化、集约化、连锁化的运营优势,为医院提供新技术、新管理、新模式,创建出一系列特色鲜明的肾脏病专科医院和血液透析中心,用无限的责任感和专业度,服务于广大肾病患者。未来,新华医疗,将以集团化、专业化、规范化的全新面貌,为更多患者提供完善医疗服务,成就发展健康产业之路的宏伟梦想。

公司以山东核心区域为研发、制造、营销和管理总部,同时有北京核心区域、上海核心区域。

心系健康,诚信天下。站在新的历史起点上,面对新的发展机遇,新华医疗将一如既往,与时俱进,以自信、创新和拼搏,去勇敢面对困难和挑战,为人类健康事业、为铸造中国医疗器械产业的丰碑、打造世界知名医疗器械生产企业而继续努力奋斗!

英文翻译:In September 2002, Shandong Xinhua medical device Co., Ltd. was listed on the Shanghai Stock Exchange and is now the chairman of China Medical Device Industry Association. Shandong Xinhua Medical Equipment Co., Ltd. always adheres to the Qilu culture of striving for integrity, the modern enterprise culture centered on users as the core values of the enterprise, encourages morale with goals, rallies people with development, improves quality with innovation, builds strength with culture, firmly takes the road of health industry, firmly takes the road of technological innovation, and firmly takes the road of capital The way of operation, with medical devices and equipment, pharmaceutical equipment, medical services three business sectors. In the medical equipment sector, nine advanced product lines with excellent configuration and complete technology have been formed, covering infection control, radiotherapy and imaging, surgical equipment and orthopedics, operating room engineering and equipment, oral equipment and consumables, in vitro diagnostic reagents and instruments, biomaterials and consumables, dialysis equipment and consumables, medical environmental protection and other fields. The pharmaceutical equipment sector is composed of four engineering technology centers, including biopharmaceutical, special infusion, traditional Chinese medicine preparation and solid preparation. It has eight product technology branches and five holding companies, integrating the R & D, manufacturing and sales of pharmaceutical equipment. In addition to the production of conventional pharmaceutical equipment, it provides the high-quality service of "pharmaceutical technology, pharmaceutical equipment, pharmaceutical engineering"; at the same time, it provides the whole package service for the construction of chemical medicine, biological medicine, plant medicine factories, and solves all the worries for customers. In the field of medical services, Xinhua medical continues to enhance its brand competitiveness and reputation. With professional investment, construction, operation, procurement and service platform, we will build a modern hospital group with advanced medical concept, cutting-edge scientific research level, brand management chain and organic integration of resources. At the same time, Xinhua medical is also actively expanding kidney health services, taking advantage of the company's professional, intensive and chain operation advantages to provide new technology, new management and new mode for the hospital, creating a series of distinctive kidney disease specialized hospitals and hemodialysis centers, serving the vast number of nephrotic patients with unlimited sense of responsibility and professionalism. In the future, Xinhua medical will take a new look of collectivization, specialization and standardization to provide more patients with perfect medical services and achieve the grand dream of developing health industry. The company takes the core area of Shandong Province as its R & D, manufacturing, marketing and management headquarters, and has the core areas of Beijing and Shanghai. Heart health, integrity world. Standing at a new historical starting point and facing new development opportunities, Xinhua medical will, as always, keep pace with the times, bravely face difficulties and challenges with self-confidence, innovation and hard work, and continue to strive for the cause of human health, the building of a monument of China's medical device industry and the building of a world-famous medical device manufacturer!

本文链接: https://www.waitui.com/brand/f0c49f885.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

逐际动力发布TRON 1感知拓展套件,将感知科研拓展到多地形三维空间

36氪获悉,逐际动力LimX Dynamics发布多形态双足机器人TRON 1感知拓展套件,通过集成激光雷达和深度相机,搭载高算力模组,依托TRON 1的复杂地形运动能力,将感知相关科研任务拓展到多地形三维空间,为三维建图、重定位、路径规划、自主导航等关键科研任务提供开箱即用的软硬件支持。

16分钟前

2024年全国消协组织为消费者挽回经济损失12.8亿元

中国消费者协会今天(20日)发布《中国消费者权益保护状况年度报告(2024)》,其中指出,2024年我国消费者权益保护在立法、行政以及社会各方面取得重要突破。年度报告显示,2024年,《中华人民共和国消费者权益保护法实施条例》颁布实施,进一步夯实了消费者权益保护的法治根基。全国消协组织全年共受理消费者投诉176.19万件,为消费者挽回经济损失12.8亿元,有力保障广大消费者的合法权益。(央视新闻)

16分钟前

以旧换新“国补”将持续,中央资金将分批下达

从有关部门获悉,消费品以旧换新加力扩围政策没有变化,补贴资金使用进度符合预期,第三、四季度中央资金将陆续下达。据了解,今年以来,按照党中央、国务院部署,国家发展改革委、财政部、商务部等相关部门共同落实加力扩围实施“两新”政策,延续2024年好的经验做法,直接向地方安排3000亿元国债资金加力扩围实施消费品以旧换新,在今年年度内全年实施。今年1月和4月已分别下达两批共计1620亿元中央资金,支持地方做好一、二季度消费品以旧换新工作。后续还将有1380亿元中央资金在三、四季度分批有序下达。 (新华社)

16分钟前

传小红书商业化负责人离职,本人回应:属实,将参与AI和机器人相关创业

有报道称,小红书商业化部门商业化互联网行业负责人白哉(赵维晨)已经离职。据了解,赵维晨去年4月加入小红书以来,担任商业化互联网行业负责人,向小红书首席营销官王雅娟(薯名:之恒)汇报,负责拓展电商、网服、游戏等新兴领域的广告合作。对此,赵维晨回应:“确实已经离开小红书,去做AI和机器人相关的创业了。”(新浪科技)

16分钟前

半日主力资金加仓电力设备股,抛售计算机股

主力资金早间净流入电力设备、银行、食品饮料等板块,净流出计算机、通信、传媒等板块。具体到个股来看,强力新材、中京电子、中国平安获净流入9.48亿元、7.92亿元、6.96亿元。净流出方面,东信和平、新易盛、沪电股份遭抛售5.55亿元、4.86亿元、3.99亿元。(第一财经)

16分钟前

本页详细列出关于SHINVA新华的品牌信息,含品牌所属公司介绍,SHINVA新华所处行业的品牌地位及优势。
咨询